Results 41 to 50 of about 52,183 (303)

Patch testing in fixed drug eruptions: a 20-year review. [PDF]

, 2011
BACKGROUND: The fixed drug eruption is a common adverse drug reaction. Clear identification of the culprit drug is not always possible in the clinical setting, and oral rechallenge may induce new lesions or severe reactions.
Andrade, P, Brinca, A, Gonçalo, Margarida   +2 more
core   +1 more source

Pharmacogenetic biomarkers associated with risk of developing severe drug eruptions and clinical implementation of HLA genetic testing

Allergology International
The association of human leukocyte antigen (HLA) with the risk of drug-induced skin eruptions has been extensively studied. The sensitivity of the association of specific HLA alleles with drug eruptions ranges from approximately 50 to 100%, indicating a ...
Taisei Mushiroda
doaj   +1 more source

Therapeutic evaluation of homeopathic treatment for canine oral papillomatosis [PDF]

, 2020
Aim: A study was conducted to evaluate the ameliorative potential of homeopathic drugs in combination (Sulfur 30C, Thuja 30C, Graphites 30C, and Psorinum 30C) in 16 dogs affected with oral papillomatosis which was not undergone any previous treatment ...
Kumar, M. Asok, Pavulraj, Selvaraj, Raj, P. Albert Arockia, Sabithabanu, S., Sangeetha, S., Shanmugapriya, R.   +5 more
core   +2 more sources

Extramedullary Disease—Achilles Heel in Myeloma?

American Journal of Hematology, EarlyView.
ABSTRACT Despite advances in therapy, extramedullary disease (EMD) remains an aggressive form of multiple myeloma associated with poor outcomes. Patients with true EMD, in which plasmacytomas have become completely independent of bone, have a particularly poor prognosis. The pathogenesis of EMD is driven by complex mechanisms involving loss of adhesion
Shaji Kumar, Joshua Richter, Saad Z. Usmani, Yael C. Cohen, Jing Christine Ye, María‐Victoria Mateos, Vania Hungria, Elena Zamagni   +7 more
wiley   +1 more source

Fixed drug eruption caused by tadalafil - case report [PDF]

Anais Brasileiros de Dermatologia, 2013
Fixed drug eruptions (FDE) are commonly reported type of mucocutaneous drug eruption. The aim of this paper is to present a patient with multiple mucocutaneous erythema fixum type lesions caused by oral tadalafil use.
Milan Bjekic, Milica Markovic, Sandra Sipetic   +2 more
doaj   +1 more source

Lichenoid drug eruption induced by teriflunomide

Annals of Indian Academy of Neurology, 2023
Lichenoid drug eruptions are a type of skin reaction that is caused by medication and mimics idiopathic lichen planus. Various medications have been known to cause lichenoid drug eruptions, such as antibiotics, anti-convulsants, anti-diabetics, anti ...
Fatima-Zahra Agharbi, Jehanne Aasfara, Kenza Oqbani, Khalqui Slamti, Soumiya Chiheb   +4 more
doaj   +1 more source

Overview of Genus Prosopis Toxicity Reports and its Beneficial Biomedical Properties [PDF]

, 2016
Secondary plant metabolites are regarded as promising sources of plant-protecting substances and they are one of the most important lines of plant defense against pests. The range of cellular targets for these substances is very wide and covers metabolic
Gamarra Luques, Carlos Diego, Hapon, María Belén, Persia, Andres, Rinaldini, Estefanía   +3 more
core   +1 more source

Drug resistance in Plasmodium falciparum from the Chittagong Hill Tracts, Bangladesh. [PDF]

, 2004
OBJECTIVE: To assess the efficacy of antimalarial treatment and molecular markers of Plasmodium falciparum resistance in the Chittagong Hill Tracts of Bangladesh. METHODS: A total of 203 patients infected with P.
Anderson, T C, Brockman, A, Chakma, S, Nair, S, Talukder, L, van den Broek, I, van der Wardt, S   +6 more
core   +2 more sources

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

Molecular Layer Deposition for Surface Modification of Emerging Battery Systems

EcoEnergy, EarlyView.
This review provides a timely and comprehensive survey on the applications of molecular layer deposition (MLD) in surface modifications of emerging battery systems, including lithium‐ion batteries (LIBs), lithium metal batteries (LMBs), sodium‐based batteries (NBs), and solid‐state batteries (SSBs).
Xiangbo Meng
wiley   +1 more source